Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy.
Ripa RS, Holmvang L, Maynard C, Sejersten M, Clemmensen P, Grande P, Lindahl B, Lagerqvist B, Wallentin L, Wagner GS. Ripa RS, et al. J Electrocardiol. 2005 Jul;38(3):180-6. doi: 10.1016/j.jelectrocard.2005.03.011. J Electrocardiol. 2005. PMID: 16003697 Clinical Trial.
In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial).
Jørgensen E, Ripa RS, Helqvist S, Wang Y, Johnsen HE, Grande P, Kastrup J. Jørgensen E, et al. Among authors: ripa rs. Int J Cardiol. 2006 Jul 28;111(1):174-7. doi: 10.1016/j.ijcard.2005.06.045. Epub 2005 Jul 28. Int J Cardiol. 2006. PMID: 16054717
Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sørensen M, Jørgensen E, Fang W, Kastrup J. Wang Y, et al. Among authors: ripa rs. Heart. 2006 Jun;92(6):768-74. doi: 10.1136/hrt.2005.069799. Epub 2005 Oct 26. Heart. 2006. PMID: 16251230 Free PMC article.
Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
Ripa RS, Jørgensen E, Wang Y, Thune JJ, Nilsson JC, Søndergaard L, Johnsen HE, Køber L, Grande P, Kastrup J. Ripa RS, et al. Circulation. 2006 Apr 25;113(16):1983-92. doi: 10.1161/CIRCULATIONAHA.105.610469. Epub 2006 Mar 12. Circulation. 2006. PMID: 16531621 Clinical Trial.
Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.
Sejersten M, Birnbaum Y, Ripa RS, Maynard C, Wagner GS, Clemmensen P; DANAMI-2 Investigators. Sejersten M, et al. Among authors: ripa rs. Heart. 2006 Nov;92(11):1577-82. doi: 10.1136/hrt.2005.085639. Epub 2006 Jun 1. Heart. 2006. PMID: 16740918 Free PMC article. Clinical Trial.
Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy.
Sejersten M, Ripa RS, Maynard C, Grande P, Andersen HR, Wagner GS, Clemmensen P; DANAMI-2 investigators. Sejersten M, et al. Among authors: ripa rs. Am Heart J. 2007 Jul;154(1):61.e1-8. doi: 10.1016/j.ahj.2007.04.003. Am Heart J. 2007. PMID: 17584552 Clinical Trial.
97 results